Press Releases

Date Title and Summary View
Toggle Summary Over One Hundred NxStage Patients Celebrate Ten-Year Anniversary on Home Hemodialysis with the System One
LAWRENCE, Mass. , Aug. 4, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, joins over one hundred NxStage patients in celebrating their ten-year anniversary on home hemodialysis with the NxStage ® System One
View HTML
Toggle Summary NxStage® to Report Second Quarter 2017 Financial Results
LAWRENCE, Mass. , July 10, 2017 /PRNewswire/ --  NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced plans to release its financial results for the second quarter ended June 30, 2017 , on Wednesday, August 9, 2017 , before
View HTML
Toggle Summary NxStage Launches 3rd Annual Nurse Hero Contest to Celebrate Home Hemodialysis Nurses
LAWRENCE, Mass. , June 15, 2017 /PRNewswire/ -- NxStage Medical , Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today launched its 3 rd annual Nurse Hero contest to honor the critical role home hemodialysis nurses play in educating, training and
View HTML
Toggle Summary New Data from KIHDNEy Cohort Shows Improved Biochemical Outcomes and Broad Range Patient Suitability with More Frequent Hemodialysis Using the NxStage System One
Data presentations to be showcased at the 54th ERA-EDTA Congress
View HTML
Toggle Summary NxStage Announces Second Quarter 2017 Investor Conference Schedule
LAWRENCE, Mass. , May 25, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank , Chief Executive Officer, plans to participate in the following schedule of investor conferences.
View HTML
Toggle Summary NxStage Medical Announces FDA Clearance for its New System One Hemodialysis System
LAWRENCE, Mass. , May 10, 2017 /PRNewswire/ --  NxStage Medical, Inc . (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received FDA clearance.  This innovative system consists of new features and
View HTML
Toggle Summary NxStage Reports First Quarter Financial Results
- Revenue Increases to $96.8 million, up 9% from Q1'FY16- Company Reaffirms Total Revenue Guidance and Profitability for 2017- Company Continues to Advance NxGen Hemodialysis System and Innovative Pipeline
View HTML
Toggle Summary NxStage® to Report First Quarter 2017 Financial Results
LAWRENCE, Mass. , April 6, 2017 /PRNewswire/ --  NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced plans to release its financial results for the first quarter ended March 31, 2017 , on Tuesday, May 9, 2017 , before the
View HTML
Toggle Summary New Data Shows Significant Potential Cost Savings with On-Site Hemodialysis in Skilled Nursing Facilities
On-site hemodialysis with NxStage System One provides cost-effective alternative to expensive transportation services associated with off-site dialysis
View HTML
Toggle Summary NxStage Medical Announces CE Mark for its NxGen Hemodialysis System
LAWRENCE, Mass. , March 2, 2017 /PRNewswire/ --  NxStage Medical, Inc . (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received CE Mark approval.  This innovative system consists of new features
View HTML